John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

Biliary duct tumors:What is the place of percutaneous biliary drainage? Volume 29, issue 2, February 2022

Figures

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7
  • Figure 8

Tables

Authors
1 Centre Hospitalier Universitaire Mohammed VI, Service de radiologie, Marrakech, Maroc
2 AP-HP – Université Paris Saclay, Hôpital Ambroise Paré, DMU Smart Imaging, Service d’imagerie médicale et de radiologie interventionnelle, 92100 Boulogne-Billancourt, France
3 Hôpital de Poissy Saint-Germain-en-Laye, Service d’imagerie médicale et de radiologie interventionnelle, 78300 Poissy, France
4 UMR 1179 INSERM/UVSQ, équipe 3 : Thérapeutiques innovantes et technologies appliquées aux troubles neuro-moteurs
5 Hôpital de Poissy Saint-Germain-en-Laye, Service d’hépato-gastroentérologie, 78300 Poissy, France
* Correspondance

Percutaneous drainage of malignant biliary obstructions is often palliative in advanced lesions Bismuth III and IV, and in case of failure or in addition to endoscopic drainage. An assessment including whole body CT and hepatobiliary MRI as well as a discussion in a multidisciplinary team are crucial steps for therapeutic options. To restore the patency of the biliary duct, the operator uses external or better internal-external drains, and also uncovered or covered metallic stents. Numerous innovations aim to increase the patency of these prostheses. An anesthetic environment is mandatory for pain and septic complications management.